Literature DB >> 1019915

Prostaglandin E2 prevents aspirin and indomethacin damage to human gastric mucosa.

M M Cohen, J M Pollett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1019915

Source DB:  PubMed          Journal:  Surg Forum        ISSN: 0071-8041


× No keyword cloud information.
  7 in total

Review 1.  Gastrointestinal cytoprotection by prostaglandins.

Authors:  T A Miller; E D Jacobson
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

2.  Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin.

Authors:  A Tarnawski; T Brzozowski; I J Sarfeh; W J Krause; T R Ulich; H Gergely; D Hollander
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

3.  Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins.

Authors:  J P Bolton; D Palmer; M M Cohen
Journal:  Am J Dig Dis       Date:  1978-04

4.  Prevention of aspirin-induced faecal blood loss by prostaglandin E2.

Authors:  M M Cohen; G Cheung; D M Lyster
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

5.  Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.

Authors:  I Bjarnason; P Williams; P Smethurst; T J Peters; A J Levi
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

6.  Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man.

Authors:  M M Cohen; L Clark; L Armstrong; J D'Souza
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

7.  The pathogenesis of the aspirin-related gastric lesion.

Authors:  J M Duggan
Journal:  J R Coll Physicians Lond       Date:  1981-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.